Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-001296
Filing Date
2025-03-28
Accepted
2025-03-28 17:19:42
Documents
92
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 1967971
2 ex10-14.htm EX-10.14 49695
3 ex10-37.htm EX-10.37 340140
4 ex21.htm EX-21 6279
5 ex23-1.htm EX-23.1 4201
6 ex31-1.htm EX-31.1 12700
7 ex31-2.htm EX-31.2 12920
8 ex32.htm EX-32 9180
9 ex10-37_01.jpg GRAPHIC 2319
10 ex10-37_02.jpg GRAPHIC 2275
  Complete submission text file 0001641172-25-001296.txt   9320576

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE envb-20241231.xsd EX-101.SCH 70680
12 XBRL CALCULATION FILE envb-20241231_cal.xml EX-101.CAL 80210
13 XBRL DEFINITION FILE envb-20241231_def.xml EX-101.DEF 292967
14 XBRL LABEL FILE envb-20241231_lab.xml EX-101.LAB 611910
15 XBRL PRESENTATION FILE envb-20241231_pre.xml EX-101.PRE 468125
94 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 1255029
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38286 | Film No.: 25787789
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)